1-9 of 9
Authors: Robert Latek
Save search
Sort by
Journal Article
EDITOR'S CHOICE

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 Free

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 674–686, https://doi.org/10.1093/neuonc/nox208
Published: 28 October 2017
Journal Article

ATIM-16. NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143 Free

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi21, https://doi.org/10.1093/neuonc/now212.081
Published: 07 November 2016
Journal Article

IMCT-03SAFETY AND ACTIVITY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS FROM CHECKMATE-143 Free

PDF
John Sampson and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v107, https://doi.org/10.1093/neuonc/nov218.03
Published: 09 November 2015
Journal Article

CBM-06IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143 Free

PDF
Daniel E. Lowther and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v70, https://doi.org/10.1093/neuonc/nov211.06
Published: 09 November 2015
Journal Article

NIMG-18EVALUATING TUMOR PROGRESSION AND IMMUNOLOGIC REACTIONS DURING IMMUNOTHERAPY: NEUROIMAGING OBSERVATIONS FROM A MULTICENTER STUDY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA (CHECKMATE-143) Free

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v157, https://doi.org/10.1093/neuonc/nov225.18
Published: 09 November 2015
Journal Article

CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA Free

PDF
Liliana Lucca and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v69–v70, https://doi.org/10.1093/neuonc/nov211.04
Published: 09 November 2015
Journal Article

QOL-07DESCRIPTION OF CLINICAL AND PATIENT REPORTED OUTCOMES ASSESSMENTS FROM A PHASE 3, MULTICENTER, RANDOMIZED TRIAL EVALUATING NIVOLUMAB MONOTHERAPY VERSUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA: CHECKMATE-143 Free

PDF
Lakshmi Nayak and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v189, https://doi.org/10.1093/neuonc/nov230.07
Published: 09 November 2015
Journal Article

NIMG-16PSEUDOPROGRESSION AND IMMUNOTHERAPY IN GLIOBLASTOMA: A CASE SERIES FROM COHORT 1 OF CHECKMATE-143 (NCT02017717) Free

PDF
Solmaz Sahebjam and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v156, https://doi.org/10.1093/neuonc/nov225.16
Published: 09 November 2015
Journal Article

NIMG-17CENTRAL NEUROPATHOLOGY REVIEW TO ASSIST IN THE EVALUATION OF IMMUNE-RELATED TREATMENT CHANGES VERSUS DISEASE PROGRESSION IN CHECKMATE-143 Free

PDF
Shak Ramkissoon and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Pages v156–v157, https://doi.org/10.1093/neuonc/nov225.17
Published: 09 November 2015